Resistance to Rocuronium in a Patient with Propionic Acidemia Undergoing Appendectomy for Acute Appendicitis: A Case Report with Literature Review

Propionic acidemia is a rare metabolic disorder caused by a deficiency of the mitochondrial enzyme, propionyl-CoA carboxylase, which is required in the catabolic pathways of several amino acids, odd-chain fatty acids and the side chains of cholesterol. Clinically, the disorder may present with multisystemic manifestations including metabolic ketoacidosis, hyperlactatemia, hyperammonemia, developmental delay and neurological dysfunction. The key principle in managing or preventing acute exacerbations consists of protein restricted diet and avoidance of factors that may potentiate relevant catabolic pathways. We describe an unusual case of a female patient with propionic acidemia undergoing appendectomy for acute appendicitis, who was resistant to a nondepolarizing neuromuscular blocker (rocuronium). In literature, there has been reported cases of resistance to nondepolarizing neuromuscular blockers associated with certain pathologic conditions or medications, but such resistance has not been previously described in the context of propionic acidemia. Rocuronium resistance in our index patient could be attributable to a sum of potential etiologic factors including the use of valproic acid, and upper motor neuron damage, a rare complication of chronic propionic acidemia.

Propionic academia, Nondepolarizing muscle relaxants, Rocuronium, Appendicitis, Anesthesia

[1] Rafique M. Emerging trends in management of propionic acidemia. Arq Bras Endocrinol Metabol. 2014;58:237-42.

[2] Ryu J, Shin YH, Ko JS, Gwak MS, Kim GS. Intractable metabolic acidosis in a child with propionic acidemia undergoing liver transplantation – a case report. Korean J Anesthesiol. 2013;65:257-61.

[3] Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.

[4] Harker HE, Emhardt JD, Hainline BE. Propionic acidemia in a four-month-old male: a case study and anesthetic implications. Anesth Analg. 2000;91:309-11.

[5] Soberón JR, Elliott CE, Bland KS, Weinberg GL. Peripheral nerve block in a patient with propionic acidemia. Reg Anesth Pain Med. 2014;39:560-1.

[6] Sebens EL. A child with propionic acidemia undergoing dental restorations: a case report. AANA J. 2011;79:295-299.

[7] Silva HM, Nassogne MC, Smets F, Stéphenne X, Scheers I, Veyckemans F, et al. Liver Transplantation for Propionic Acidemia. J Pediatr Gastroenterol Nutr. 2017;64:e73-e76.

[8] Deana C, Barbariol F, D’Incà S, Pompei L, Rocca GD. SUGAM-MADEX Versus Neostigmine After ROCURONIUM Continuous Infusion in Patients Undergoing Liver Transplantation. BMC Anes-thesiol. 2020;20:70.

[9] Fuchs-Buder T, Schlaich N, Ziegenfuss T. [Rocuronium for anes-thesia induction in elective procedures. Time course of muscular blockade and intubation after administration of 2-compartment ED95 (0.6 mg/kg) and dose reduction (0.4 mg/kg)]. Anaesthesist. 1999;48:164-8.

[10] Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down Regulation of Skeletal Muscle Acetylcholine Receptors. Effects on Neuromuscular Blockers. Anesthesiology. 1992;76:822-43.

[11] Capuano A, Sullo MG, Rafaniello C, Sportiello L, Fusco P, De Vizia M, et al. Complete resistance after maximal dose of rocuronium. J Pharmacol Pharmacother. 2015;6:175-178.

[12] Soriano SG, Martyn JA. Antiepileptic-induced Resistance to Neu-romuscular Blockers: Mechanisms and Clinical Significance. Clin Pharmacokinet. 2004;43:71-81.

[13] Anderson GD. A Mechanistic Approach to Antiepileptic Drug Interactions. Ann Pharmacother. 1998;32:554-63.

[14] Lien CA, Eikermann M. 22 – Neuromuscular Blockers and Reversal Drugs. In: Hemmings HC, Egan TD, editors. Pharmacology and Physiology for Anesthesia, 2nd ed. Philadelphia, PA: Elsevier, Inc. 2019.p.428-454.

[15] Kim MH, Hwang JW, Jeon YT, Do SH. Effects of valproic acid and magnesium sulphate on rocuronium requirement in patients undergoing craniotomy for cerebrovascular surgery. Br J Anaesth. 2012;109:407-12.